Using Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in Obese Patients: A Real-Life, Single-Center Observational Study. [PDF]
Oliva A +5 more
europepmc +1 more source
Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical Trials. [PDF]
Gonzalez PL +8 more
europepmc +1 more source
Dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in pediatric patients: a case series. [PDF]
Garbo V +7 more
europepmc +1 more source
Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infections. [PDF]
Bhavnani SM +9 more
europepmc +1 more source
Prescriptive appropriateness of dalbavancin in acute bacterial skin and skin structure infections in adults: an integrated approach between clinical profile, patient- and health system-related factors and focus on environmental impact. [PDF]
Di Gennaro F.
europepmc +1 more source
Afabicin, a First-in-Class Antistaphylococcal Antibiotic, in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Clinical Noninferiority to Vancomycin/Linezolid. [PDF]
Wittke F +7 more
europepmc +1 more source
Single-Dose Treatment With Dalbavancin for Acute Bacterial Skin and Skin Structure Infection
Michael Dunne +5 more
openaire +1 more source

